ArticleFundamental & clinical pharmacology2022

COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.

Amandine Dernoncourt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.